Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | conserved hypothetical protein | 0.0667 | 0.1422 | 0.1977 |
Schistosoma mansoni | biogenic amine (5HT) receptor | 0.0584 | 0.0325 | 0.5 |
Echinococcus multilocularis | serotonin receptor | 0.0584 | 0.0325 | 0.0451 |
Brugia malayi | Adenylyl cyclase protein | 0.0559 | 0 | 0.5 |
Echinococcus multilocularis | tm gpcr rhodopsin gpcr rhodopsin superfamily | 0.1102 | 0.7194 | 1 |
Echinococcus multilocularis | serotonin receptor | 0.0584 | 0.0325 | 0.0451 |
Onchocerca volvulus | Adenylate cyclase type 3 homolog | 0.1239 | 0.9 | 1 |
Echinococcus granulosus | biogenic amine 5HT receptor | 0.0584 | 0.0325 | 0.0451 |
Echinococcus granulosus | tm gpcr rhodopsin | 0.1102 | 0.7194 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0584 | 0.0325 | 0.0325 |
Loa Loa (eye worm) | hypothetical protein | 0.121 | 0.8616 | 0.8616 |
Echinococcus granulosus | adenylate cyclase type IX | 0.0846 | 0.3792 | 0.5271 |
Loa Loa (eye worm) | hypothetical protein | 0.0584 | 0.0325 | 0.0325 |
Echinococcus multilocularis | adenylate cyclase type IX | 0.0846 | 0.3792 | 0.5271 |
Echinococcus granulosus | hypothetical protein | 0.0745 | 0.246 | 0.342 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | Tested for growth hormone secretagogue activity in A93 cell line using a calcium flux assay at 10 uM (Relative to compound T1); NA means not active | ChEMBL. | 15294000 | |
Activity (functional) | 0 | Tested for growth hormone secretagogue activity in A93 cell line using a calcium flux assay at 10 uM (Relative to compound T1); NA means not active | ChEMBL. | 15294000 |
Ki (binding) | uM | Binding affinity for human growth hormone secretagogue receptor using [125I]-ghrelin; NM means not measured | ChEMBL. | 15294000 |
Ki (binding) | 0 uM | Binding affinity for human growth hormone secretagogue receptor using [125I]-ghrelin; NM means not measured | ChEMBL. | 15294000 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.